EP1799240A4 - Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette - Google Patents

Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette

Info

Publication number
EP1799240A4
EP1799240A4 EP05797693A EP05797693A EP1799240A4 EP 1799240 A4 EP1799240 A4 EP 1799240A4 EP 05797693 A EP05797693 A EP 05797693A EP 05797693 A EP05797693 A EP 05797693A EP 1799240 A4 EP1799240 A4 EP 1799240A4
Authority
EP
European Patent Office
Prior art keywords
treatment
bone disorders
anabolic drugs
skeletal anabolic
skeletal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05797693A
Other languages
German (de)
English (en)
Other versions
EP1799240A2 (fr
Inventor
Andrew F Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osteotrophin LLC
Original Assignee
Osteotrophin LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteotrophin LLC filed Critical Osteotrophin LLC
Publication of EP1799240A2 publication Critical patent/EP1799240A2/fr
Publication of EP1799240A4 publication Critical patent/EP1799240A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP05797693A 2004-09-16 2005-09-14 Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette Withdrawn EP1799240A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61028304P 2004-09-16 2004-09-16
PCT/US2005/032706 WO2006033912A2 (fr) 2004-09-16 2005-09-14 Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette

Publications (2)

Publication Number Publication Date
EP1799240A2 EP1799240A2 (fr) 2007-06-27
EP1799240A4 true EP1799240A4 (fr) 2009-07-22

Family

ID=36090476

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05797693A Withdrawn EP1799240A4 (fr) 2004-09-16 2005-09-14 Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette

Country Status (6)

Country Link
EP (1) EP1799240A4 (fr)
JP (1) JP2008513459A (fr)
AU (1) AU2005287139A1 (fr)
CA (1) CA2580281A1 (fr)
MX (1) MX2007003185A (fr)
WO (1) WO2006033912A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
RU2604809C2 (ru) 2010-05-13 2016-12-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги паратиреоидного гормона и их применение

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015195B2 (en) * 2002-01-10 2006-03-21 Osteotrophin, Llc Treatment of bone disorders with skeletal anabolic drugs
CA2496618A1 (fr) * 2002-05-23 2003-12-04 Michael Holick Utilisation d'analogues peptidiques d'hormone parathyroide pour le traitement de l'atrophie vaginale

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HORWITZ MARA J ET AL: "Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.", THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM FEB 2003, vol. 88, no. 2, February 2003 (2003-02-01), pages 569 - 575, XP002530462, ISSN: 0021-972X *

Also Published As

Publication number Publication date
WO2006033912B1 (fr) 2006-09-08
WO2006033912A2 (fr) 2006-03-30
WO2006033912A3 (fr) 2006-06-29
EP1799240A2 (fr) 2007-06-27
JP2008513459A (ja) 2008-05-01
CA2580281A1 (fr) 2006-03-30
MX2007003185A (es) 2007-10-16
AU2005287139A1 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
IL185052A0 (en) Treatment of bone disorders
HK1207821A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
IL178815A0 (en) The treatment of respiratory disease
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
EP2166837A4 (fr) Combinaison médicamenteuse utilisable pour le traitement de troubles cutanés
IL184425A0 (en) Cxcr4 antagonists for the treatment of medical disorders
IL188204A0 (en) Combination therapy for the treatment of immunoinflammatory disorders
EP1926521A4 (fr) Dispositifs et procedes pour liberer des substances therapeutiques pour le traitement de la sinusite et d'autres troubles
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ZA200801667B (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
EP1962869A4 (fr) Traitement de maladies respiratoires
GB0404656D0 (en) Treatment of spinal conditions
GB0410399D0 (en) The treatment of respiratory disease
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
EP1799240A4 (fr) Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette
EP1924286A4 (fr) Procédé thérapeutique et/ou phropylactique pour le traitement d'une maladie auto-immune
GB0400802D0 (en) Compounds for the treatment of disease
EP1846013A4 (fr) Traitement de dermatoses
ZA200607463B (en) New pharmaceutical compositions for the treatment of sexual disorders II
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
GB0417474D0 (en) Treatment of respiratory disorders
GB0423245D0 (en) Treatment of breathing disorders

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070412

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090618

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090918